Curcumin-enhanced antitumor effects of sorafenib via regulating the metabolism and tumor microenvironment
- 20 June 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (7) , 6422-6432
Abstract
Curcumin, the main active ingredient of turmeric, is widely used as a kind of food additive and also displays a range of pharmacological activities, such as anti-inflammation, anti-tumor, liver and kidney protection, and so forth. Sorafenib was the first targeted agent against hepatocellular carcinoma (HCC), whose intolerance is related to the promotion of lipid synthesis and epithelial-to-mesenchymal transition (EMT) formation. In this study, biochemical analysis, immune cells composition, the tumor microenvironment, metabolomics, and relative metabolic enzymes and transporters were detected in H22-bearing mice treated with curcumin combined with sorafenib vs. control groups. It was found that curcumin protected against liver cancer progression through reducing the level of alpha fetoprotein in liver tissues, increasing the number of immune cells, like NK cells, inhibiting EMT via the regulation of IL-6/JAK/STAT3 and IL-1β/NF-κB pathways, suppressing anaerobic glycolysis through the inhibition of LDH and HIF-1α, and decreasing the lipid synthesis via the downregulation of FASN, and upregulated the serum HDL-C and mRNA levels of apoA1 in the sorafenib-treated mice. Furthermore, curcumin regulation of the disorder of glycolipid metabolism and EMT was also based on the PI3K/AKT pathway. A docking study was performed and proved the strong affinity between curcumin and the proteins of STAT3, FASN, and AKT. All in all, this experiment provided evidence for the addition of curcumin in the diet to enhance the antitumor efficacy of sorafenib through activating immune function, downregulating EMT, and reversing disorders of the metabolism.Keywords
Funding Information
- National Natural Science Foundation of China (81673647)
- National Natural Science Foundation of China (81503086)
- Tianjin Municipal Science and Technology Committee (18PTSYJC00140)
This publication has 33 references indexed in Scilit:
- Effects of Curcumin on Tobacco Smoke-induced Hepatic MAPK Pathway Activation and Epithelial-Mesenchymal TransitionIn VivoPhytotherapy Research, 2017
- Curcumin Attenuates N-Nitrosodiethylamine-Induced Liver Injury in Mice by Utilizing the Method of MetabonomicsJournal of Agricultural and Food Chemistry, 2017
- Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signalingBiomedicine & Pharmacotherapy, 2016
- Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?Expert Review of Anticancer Therapy, 2016
- Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic MarkersOxidative Medicine and Cellular Longevity, 2016
- Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancerMolecular Therapy-Oncolytics, 2016
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinomaCancer Letters, 2015
- Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancerJournal of Hepatology, 2015
- Tetrachloro-p-benzoquinone induces hepatic oxidative damage and inflammatory response, but not apoptosis in mouse: The prevention of curcuminToxicology and Applied Pharmacology, 2014
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growthCancer Letters, 2013